Peter Valent

Revised International Prognostic Scoring System for Myelodysplastic Syndromes

Peter L. Greenberg, Heinz Tuechler, Julie Schanz et al. · Blood · 2012 · 3.1K citations · Full text

Medicine, Hematology, Internal Medicine +12

RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia

Johannes Zuber, Junwei Shi, Eric Wang et al. · Nature · 2011 · 1.9K citations

Life Sciences, Molecular Biology, Molecular Genetics +9

Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Elsa Bernard, Heinz Tuechler, Peter L. Greenberg et al. · NEJM Evidence · 2022 · 813 citations · Full text

Medicine, Genetics, Hematology +16

New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients

Detlef Haase, Ulrich Germing, Julie Schanz et al. · Blood · 2007 · 789 citations · Full text

Life Sciences, Genetics, Oncology +16

Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes

Peter Valent, Amy D. Klion, Hans‐Peter Horny et al. · Journal of Allergy and Clinical Immunology · 2012 · 761 citations · Full text

Medicine, Pathology, Dermatopathology +8